Schedule 13D ownership disclosure
Oruka Therapeutics Inc
Security class unavailable · CUSIP: 687604108
Event date: 2024-11-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-101117
- Form type
- SC 13D
- Filer
- Fairmount Funds Management LLC
- CIK
- CIK 1802528
- Filed
- Nov 21, 2024
- Reporting period
- Nov 19, 2024
- Description
- Schedule 13D beneficial ownership